Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Intuitive Surgical, Inc. (ISRG) vs Johnson Controls International PLC (JCI) Price & Performance

Intuitive Surgical, Inc.Trade
Johnson Controls International PLCTrade

Price performance (Past 24H)

Key statistics

Intuitive Surgical, Inc. vs Johnson Controls International PLC — how do they compare? Intuitive Surgical, Inc. trades at $424 (market cap $146.76B), while Johnson Controls International PLC trades at $157.44 (market cap $93.28B). The key difference: Intuitive Surgical, Inc. is the larger of the two by market cap, and Johnson Controls International PLC pays a 1.04% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Johnson Controls International PLC for 65 Days on average.

ISRGJCI
Market Cap
$146.76B$93.28B
Volume
2,529,8142,786,476
Sector
HealthBasic Materials
52-Week High
$592.85$158.76
52-Week Low
$332.02$105.55
Typical Hold Time
84 Days65 Days
Enterprise Value
$141.54B$102.12B
Dividend Yield
—1.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $423.96, up 2.28% with strong bullish momentum. The stock shows robust fundamentals with 2025 revenue reaching $10.06B and net income of $2.86B, maintaining 28.45% net margins. Recent quarters consistently beat EPS estimates, while technical indicators signal bullish moving averages. Analyst consensus remains strongly positive with 70% buy ratings and $480.78 price target, representing 13% upside potential.

ISRG's leadership in robotic surgery and expanding international presence in India and Japan provide growth catalysts, though China weakness and competitive pressures present risks. The stock's premium valuation (P/E 47.64) reflects high growth expectations, requiring continued execution. Current levels near resistance at $427 may test near-term momentum ahead of Q3 earnings.

Johnson Controls International PLC

Johnson Controls International (JCI) trades at $157.44, up 0.97% on the day, reflecting strong momentum after beating earnings estimates for three consecutive quarters. The stock exhibits a bullish technical outlook, trading above key support levels, while fundamentals are supported by a 13.94% net income margin and robust ROE of 24.42%. Recent news highlights inclusion in AI industrial stock recommendations and strong Q3 2026 results with raised full-year guidance.

The outlook for JCI remains positive, driven by earnings outperformance and strong demand in thermal management and building systems. Key opportunities include expanding margins and strategic positioning in energy efficiency markets. Risks involve elevated valuation multiples and increasing debt-to-asset ratios, which could pressure the stock if growth moderates.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ISRG
92% Buy8% Sell
Avg holding period · 84 Days
JCI

No sentiment data available yet.

Top news

Latest headlines on both assets

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG →

About Johnson Controls International PLC

Johnson Controls manufactures, installs, and services HVAC systems, building management systems and controls, industrial refrigeration systems, and fire and security solutions. Commercial HVAC accounts for about 40% of sales, fire and security also represents 40% of sales, and residential HVAC, industrial refrigeration, and other solutions account for the remaining 20% of revenue. In fiscal 2021, Johnson Controls generated over $23.5 billion in revenue.

Read more on JCI →